Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Stock analysts at Zacks Research increased their FY2025 earnings per share (EPS) estimates for Phibro Animal Health in a note issued to investors on Friday, May 23rd. Zacks Research analyst R. Department now forecasts that the company will post earnings of $2.03 per share for the year, up from their prior forecast of $2.02. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2025 earnings at $0.50 EPS, Q3 2027 earnings at $0.59 EPS and FY2027 earnings at $2.32 EPS.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The business had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.
Other research analysts also recently issued research reports about the company. Barclays boosted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Morgan Stanley boosted their target price on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Thursday, May 8th. Finally, Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $20.00.
Get Our Latest Report on PAHC
Phibro Animal Health Price Performance
NASDAQ PAHC traded up $0.04 during trading on Monday, hitting $24.50. 298,690 shares of the company's stock were exchanged, compared to its average volume of 199,897. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The company has a market cap of $993.08 million, a PE ratio of 51.04, a P/E/G ratio of 0.45 and a beta of 0.62. Phibro Animal Health has a fifty-two week low of $16.16 and a fifty-two week high of $26.55. The stock's 50 day moving average price is $20.36 and its two-hundred day moving average price is $21.89.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in PAHC. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Phibro Animal Health in the fourth quarter valued at approximately $29,000. National Bank of Canada FI acquired a new position in shares of Phibro Animal Health in the first quarter valued at approximately $30,000. Lazard Asset Management LLC increased its stake in shares of Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after buying an additional 1,589 shares during the period. Aquatic Capital Management LLC bought a new stake in Phibro Animal Health in the fourth quarter valued at approximately $69,000. Finally, Virtus Fund Advisers LLC bought a new stake in Phibro Animal Health in the fourth quarter valued at approximately $69,000. Institutional investors and hedge funds own 99.34% of the company's stock.
Phibro Animal Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is currently 61.54%.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
